These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 4642718)
1. Intravenous glucose tolerance, insulin response, fasting blood glucose and serum insulin during short-term administration of a combined oral contraceptive. Nielsen FH Acta Obstet Gynecol Scand; 1972; 51(4):319-24. PubMed ID: 4642718 [No Abstract] [Full Text] [Related]
2. Serum triglyceride in women with and without a predisposition to diabetes during short-term administration of a combined oral contraception. Nelson FH Acta Obstet Gynecol Scand; 1974; 53(1):13-9. PubMed ID: 4817622 [No Abstract] [Full Text] [Related]
3. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans. Gerhards E; Lachnit U; Gaude R; Schillinger E Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760 [No Abstract] [Full Text] [Related]
4. [Comparative studies on oral glucose tolerance and serum lipids under the influence of a new oral contraceptive (SH B 209 AB: 2 mg cyproterone acetate + 0.05 mg ethinyl estradiol), the combination D-norgestrel/ethinyl estradiol and in a control group (author's transl)]. Schillinger E; Gerloff C; Wellershoff S; Wendt H; Lachnit-Fixson U Arzneimittelforschung; 1976; 26(12):2242-5. PubMed ID: 1037282 [TBL] [Abstract][Full Text] [Related]
5. The effects of oral contraceptives on glucose tolerance. Boshell BR; Roddam RF; McAdams GL; Fox OJ J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232 [No Abstract] [Full Text] [Related]
6. Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome. Adeniji AA; Essah PA; Nestler JE; Cheang KI J Womens Health (Larchmt); 2016 Jun; 25(6):638-45. PubMed ID: 26871978 [TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and insulin receptor binding in normal women and those with previous gestational diabetes. Skouby SO; Andersen O; Kühl C Am J Obstet Gynecol; 1986 Oct; 155(4):802-7. PubMed ID: 3766633 [TBL] [Abstract][Full Text] [Related]
8. Glucose and insulin levels during treatment with a combined oral contraceptive agent. Larsson-Cohn U Acta Soc Med Ups; 1971; 76(5-6):223-7. PubMed ID: 5141078 [No Abstract] [Full Text] [Related]
9. Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism. Wynn V Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):739-46. PubMed ID: 6801979 [TBL] [Abstract][Full Text] [Related]
10. Effect of long-term triphasic oral contraceptive use on glucose tolerance and insulin secretion. Gillespy M; Notelovitz M; Ellingson AB; Khan FY Obstet Gynecol; 1991 Jul; 78(1):108-14. PubMed ID: 2047050 [TBL] [Abstract][Full Text] [Related]
11. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive. Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229 [No Abstract] [Full Text] [Related]
12. Comparison of ethinylestradiol and mestranol in sequential-type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests. Leis D; Botterman P; Ermler R; Maurer U Fertil Steril; 1977 Jul; 28(7):737-40. PubMed ID: 872954 [TBL] [Abstract][Full Text] [Related]
13. A multicenter clinical investigation employing ethinyl estradiol combined with dl-norgestrel as postcoital contraceptive agent. Yuzpe AA; Smith RP; Rademaker AW Fertil Steril; 1982 Apr; 37(4):508-13. PubMed ID: 7040117 [TBL] [Abstract][Full Text] [Related]
14. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion]. Hausmann L; Goebel KM; Zehner J Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665 [TBL] [Abstract][Full Text] [Related]
15. [Effect of sequential preparation with ethinyl estradiol sulfonate soft gelatin capsules and norethindrone acetate on carbohydrate metabolism]. Nikschick S; Göretzlehner G; Männchen E; Brachmann K Zentralbl Gynakol; 1984; 106(6):368-73. PubMed ID: 6372333 [TBL] [Abstract][Full Text] [Related]
16. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone. Spellacy WN; Ellingson AB; Tsibris JC J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750 [TBL] [Abstract][Full Text] [Related]
17. Changes in insulin receptors during oral contraception. De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643 [TBL] [Abstract][Full Text] [Related]
18. Divergent effects of a combined hormonal oral contraceptive on insulin sensitivity in lean versus obese women. Cheang KI; Essah PA; Sharma S; Wickham EP; Nestler JE Fertil Steril; 2011 Aug; 96(2):353-359.e1. PubMed ID: 21676394 [TBL] [Abstract][Full Text] [Related]
19. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes. Skouby SO; Kühl C; Mølsted-Pedersen L; Petersen K; Christensen MS Am J Obstet Gynecol; 1985 Nov; 153(5):495-500. PubMed ID: 3933351 [TBL] [Abstract][Full Text] [Related]
20. Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis. Givens JR; Fort AT; Leigh JH J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:69-76. PubMed ID: 4330931 [No Abstract] [Full Text] [Related] [Next] [New Search]